Evidence map›Paper›PMID 41505662›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Sustained Benefit of Blinatumomab in Infants With

Miguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha, Andishe Attarbaschi, Gabriele Escherich, Karsten Nysom, Jan Stary, Alina Ferster, Benoit Brethon, Franco Locatelli and 6 more

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Miguel Vieira MartinsPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0002-3021-2843
Paola de LorenzoBiostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.ORCID 0009-0009-7522-5195
Rishi S KotechaAustralian and New Zealand Children's Hematology and Oncology Group, Perth, Australia.ORCID 0000-0003-1836-4075
Andishe AttarbaschiDepartment of Pediatric Hematology and Oncology, St Anna Children's Hospital, Vienna, Austria.ORCID 0000-0002-9285-6898
Gabriele EscherichGerman Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany.
Karsten NysomDepartment of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-2935-0058
Jan StaryCzech Working Group for Pediatric Hematology and CLIP (Childhood Leukemia Investigation Prague), Prague, Czechia.ORCID 0000-0002-6818-7743
Alina FersterHôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium.
Benoit BrethonDepartment of Pediatric Hematology, University Robert Debre Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Franco LocatelliDepartment of Pediatric Hematology-Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy.ORCID 0000-0002-7976-3654
Martin SchrappeALL-Berlin-Frankfurt-Münster (BFM) Group, University Medical Center Schleswig-Holstein, Kiel, Germany.ORCID 0000-0003-0034-5845
Peggy E Scholte-van HoutemPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Maria G ValsecchiBiostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.ORCID 0000-0001-5574-3504
Alwin D R HuitemaPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Rob PietersPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0003-2997-3570
Inge M van der SluisPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0002-5822-7668

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, BispecificAntineoplastic Combined Chemotherapy ProtocolsHistone-Lysine N-MethyltransferaseMyeloid-Lymphoid Leukemia ProteinPrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalFemaleGene RearrangementHumansInfantMaleTreatment OutcomeAntibodies, BispecificblinatumomabHistone-Lysine N-MethyltransferaseKMT2A protein, humanMyeloid-Lymphoid Leukemia Protein

Identifiers

PMID41505662
PMCPMC12879164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.